Investment report on Fonar from InvestorSoup.com

NewsGuard 100/100 Score

InvestorSoup.com announces an investment report featuring Fonar Corp. (Nasdaq:FONR). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

The full report is available at: http://www.investorsoup.com/lp/FONR

Get our alerts BEFORE the rest of the market. Follow us on Twitter: www.twitter.com/investorsoup

Fonar Corp. (FONR) operates in two business segments: medical equipment segment, and physician management and diagnostic services segment. FONR is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease.

Message Board Search for FONR: http://www.boardcentral.com/boards/FONR

In the report, the analyst notes:

"Total revenues for the second quarter of fiscal 2010 ended December 31, 2009, were $8.2 million as compared to $11.3 million for the same period last year which ended December 31, 2008. Total revenues for the six months ended December 31, 2009, were $15.7 million as compared to $18.1 million for the same period last year.

"The Company provides Stand-Up/Upright MRI scanners, which allows patients to be scanned in a weight-bearing condition, such as standing, sitting, or bending in any position that causes symptoms; and FONAR 360 MRI scanner, a diagnostic scanner. Health Management Corp. (HMCA) was established as a wholly owned subsidiary to enable the Company to expand into the business of providing management services to medical providers. HMCA provides management services, administrative services, office space, equipment, repair, maintenance service and clerical and other non-medical personnel to medical providers."

SOURCE InvestorSoup.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases